Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naiyer A Rizvi

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Journal for Immunotherapy of Cancer|August 18, 2016
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?Claud Grigg, Naiyer A Rizvi
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Immunotherapy for Advanced Lung CancerRamsey Asmar, Naiyer A Rizvi
Cancer Discovery|February 7, 2016
Immunotherapy and Oncogenic Pathways: The PTEN ConnectionNaiyer A Rizvi, Timothy A Chan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2020
Beyond Tumor PD-L1: Emerging Genomic Biomarkers for Checkpoint Inhibitor ImmunotherapyGalina G Lagos, Benjamin Izar, Naiyer A Rizvi
Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.
Cancer|October 5, 2002
A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinomaIrina E Popa, Kathleen Stewart, Frederick P Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
A case series of dose-limiting peripheral edema observed in patients treated with pemetrexedSandra P D'Angelo, Mark G Kris, Maria Catherine Pietanza, et al.
Radiology|November 23, 2006
Lung cancer: computerized quantification of tumor response--initial resultsBinsheng Zhao, Lawrence H Schwartz, Chaya S Moskowitz, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 30, 2014
Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MSSusan M Christner, Robert A Parise, Erica D Levine, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|August 18, 2016
PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?Claud Grigg, Naiyer A Rizvi
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Immunotherapy for Advanced Lung CancerRamsey Asmar, Naiyer A Rizvi
Cancer Discovery|February 7, 2016
Immunotherapy and Oncogenic Pathways: The PTEN ConnectionNaiyer A Rizvi, Timothy A Chan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 22, 2020
Beyond Tumor PD-L1: Emerging Genomic Biomarkers for Checkpoint Inhibitor ImmunotherapyGalina G Lagos, Benjamin Izar, Naiyer A Rizvi
Pharmacology & Therapeutics|January 22, 2018
Combining chemotherapy with PD-1 blockade in NSCLCMatthen Mathew, Thomas Enzler, Catherine A Shu, et al.
Cancer|October 5, 2002
A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinomaIrina E Popa, Kathleen Stewart, Frederick P Smith, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2019
Management Strategies for Early-Onset Pulmonary Events Associated with BrigatinibD Ross Camidge, Aliyah Pabani, Ronni M Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
A case series of dose-limiting peripheral edema observed in patients treated with pemetrexedSandra P D'Angelo, Mark G Kris, Maria Catherine Pietanza, et al.
Radiology|November 23, 2006
Lung cancer: computerized quantification of tumor response--initial resultsBinsheng Zhao, Lawrence H Schwartz, Chaya S Moskowitz, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 30, 2014
Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MSSusan M Christner, Robert A Parise, Erica D Levine, et al.
Pageof 10